Dr Reddys Laboratories Ltd (RDY)

Aishwarya Sitharam: Good day, everyone and welcome to the Quarter 4 and Full Year FY '26 Earnings Call of Dr. Reddy's Laboratories Limited. I'm Aishwarya Sitharam, Head of Investor Relations of Dr.

TheFly reported on April 23 that Goldman Sachs lowered its rating on RDY from Neutral to Sell and reduced the price target from INR 1,225 to INR 1,075, citing concerns that the company’s generic Ozempic...

Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.

On April 10, IBEF (India Brand Equity Foundation) highlighted a revision to India's growth rate forecast to 6.6% from 6.3%.

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q3 2026 Earnings Call Transcript January 21, 2026Dr. Reddy's Laboratories Limited reports earnings inline with expectations.

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2026 Earnings Call Transcript October 24, 2025Dr. Reddy's Laboratories Limited beats earnings expectations.

Operator: Ladies and gentlemen, good day, and welcome to Q1 FY '26 Earnings Conference Call of Dr. Reddy's Laboratories Limited.

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years. Dr.

Over the last 5 years, MSCI India delivered a total return in US dollars of 145% as compared to 94% for global equities and 39% for the emerging markets, according to Morgan Stanley.